Ursodeoxycholic Acid Market
According to Intent Market Research, the Ursodeoxycholic Acid Market is expected to grow from USD 1.4 Billion in 2024-e at a CAGR of 11.6% to touch USD 2.7 Billion by 2030. The Ursodeoxycholic Acid Market is dominated by key players such as AbbVie Inc., Mylan N.V., Hikma Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., and Apotex Inc.